Northern Trust’s Lyra Therapeutics LYRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-332,639
| Closed | -$42K | – | 4458 |
|
|
2025
Q1 | $42K | Buy |
332,639
+46,329
| +16% | +$5.85K | ﹤0.01% | 4250 |
|
|
2024
Q4 | $59.1K | Buy |
286,310
+103,026
| +56% | +$21.3K | ﹤0.01% | 4244 |
|
|
2024
Q3 | $47.1K | Buy |
183,284
+99,424
| +119% | +$25.6K | ﹤0.01% | 4224 |
|
|
2024
Q2 | $23.2K | Buy |
83,860
+23,365
| +39% | +$6.47K | ﹤0.01% | 4319 |
|
|
2024
Q1 | $376K | Sell |
60,495
-1,054
| -2% | -$6.56K | ﹤0.01% | 3656 |
|
|
2023
Q4 | $323K | Buy |
61,549
+4,540
| +8% | +$23.8K | ﹤0.01% | 3702 |
|
|
2023
Q3 | $223K | Buy |
57,009
+27,296
| +92% | +$107K | ﹤0.01% | 3769 |
|
|
2023
Q2 | $122K | Sell |
29,713
-116
| -0.4% | -$477 | ﹤0.01% | 3983 |
|
|
2023
Q1 | $60K | Hold |
29,829
| – | – | ﹤0.01% | 4216 |
|
|
2022
Q4 | $93.7K | Hold |
29,829
| – | – | ﹤0.01% | 4108 |
|
|
2022
Q3 | $149K | Hold |
29,829
| – | – | ﹤0.01% | 3987 |
|
|
2022
Q2 | $169K | Buy |
+29,829
| New | +$169K | ﹤0.01% | 3989 |
|
|
2021
Q2 | – | Sell |
-64,451
| Closed | -$746K | – | 4617 |
|
|
2021
Q1 | $746K | Sell |
64,451
-3,544
| -5% | -$41K | ﹤0.01% | 3693 |
|
|
2020
Q4 | $775K | Buy |
67,995
+19,108
| +39% | +$218K | ﹤0.01% | 3605 |
|
|
2020
Q3 | $547K | Sell |
48,887
-2,970
| -6% | -$33.2K | ﹤0.01% | 3587 |
|
|
2020
Q2 | $587K | Buy |
+51,857
| New | +$587K | ﹤0.01% | 3510 |
|